{"name": "Akebia Therapeutics",
 "permalink": "akebia-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/akebia-therapeutics",
 "homepage_url": "http://www.akebia.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "513-618-0931",
 "description": "pharmaceutical company",
 "created_at": "Fri Sep 18 13:12:34 UTC 2009",
 "updated_at": "Wed Jun 05 03:45:46 UTC 2013",
 "overview": "\u003Cp\u003EAkebia Therapeutics, Inc., a pharmaceutical company, focuses on treatments for ischemia and improvement of vascular disease. It engages in the clinical development of compounds for the treatment of anemia and ischemia-related disorders. The company offers Omacor for hypertriglyceridemia; and Actonel for osteoporosis. Its products include prolyl hydroxylase enzyme and phosphatase enzyme. Akebia Therapeutics, Inc. was founded in 2007 and is based in Cincinnati, Ohio.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       50],
      "assets/images/resized/0006/0146/60146v1-max-150x150.jpg"],
     [[240,
       81],
      "assets/images/resized/0006/0146/60146v1-max-250x250.jpg"],
     [[240,
       81],
      "assets/images/resized/0006/0146/60146v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Co-Chairman",
    "person":
     {"first_name": "Muneer",
      "last_name": "A. Satter",
      "permalink": "muneer-a-satter",
      "image": null}},
   {"is_past": false,
    "title": "Member, Board of Directors",
    "person":
     {"first_name": "Duane",
      "last_name": "Nash",
      "permalink": "duane-nash",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$83.1M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://onbiovc.com/akebia-therapeutics-inc-series-a-16m/",
    "source_description": "Akebia Therapeutics, Inc.: Series A $16M",
    "raised_amount": 16000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 9,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novartis Venture Fund",
         "permalink": "novartis-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/9083/59083v2-max-150x150.png"],
             [[250,
               117],
              "assets/images/resized/0005/9083/59083v2-max-250x250.png"],
             [[318,
               150],
              "assets/images/resized/0005/9083/59083v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Technology Venture Investors",
         "permalink": "technology-venture-investors",
         "image":
          {"available_sizes":
            [[[150,
               71],
              "assets/images/resized/0003/0995/30995v2-max-150x150.png"],
             [[197,
               94],
              "assets/images/resized/0003/0995/30995v2-max-250x250.png"],
             [[197,
               94],
              "assets/images/resized/0003/0995/30995v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Triathlon Medical Venture Partners",
         "permalink": "triathlon-medical-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0004/5663/45663v2-max-150x150.png"],
             [[200,
               66],
              "assets/images/resized/0004/5663/45663v2-max-250x250.png"],
             [[200,
               66],
              "assets/images/resized/0004/5663/45663v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Athenian Venture Partners",
         "permalink": "athenian-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0003/6232/36232v4-max-150x150.jpg"],
             [[250,
               98],
              "assets/images/resized/0003/6232/36232v4-max-250x250.jpg"],
             [[450,
               177],
              "assets/images/resized/0003/6232/36232v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sigvion Capital",
         "permalink": "sigvion-capital",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0006/0147/60147v1-max-150x150.jpg"],
             [[241,
               64],
              "assets/images/resized/0006/0147/60147v1-max-250x250.jpg"],
             [[241,
               64],
              "assets/images/resized/0006/0147/60147v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.akebia.com/news/Akebia_Srs_B_Financing.pdf",
    "source_description": "AKEBIA COMPLETES $22M SERIES B FINANCING",
    "raised_amount": 22000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 4,
    "funded_day": 26,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novartis Venture Fund",
         "permalink": "novartis-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/9083/59083v2-max-150x150.png"],
             [[250,
               117],
              "assets/images/resized/0005/9083/59083v2-max-250x250.png"],
             [[318,
               150],
              "assets/images/resized/0005/9083/59083v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Venture Investors",
         "permalink": "venture-investors",
         "image":
          {"available_sizes":
            [[[150,
               40],
              "assets/images/resized/0006/2067/62067v1-max-150x150.jpg"],
             [[217,
               58],
              "assets/images/resized/0006/2067/62067v1-max-250x250.jpg"],
             [[217,
               58],
              "assets/images/resized/0006/2067/62067v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Triathlon Medical Venture Partners",
         "permalink": "triathlon-medical-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0004/5663/45663v2-max-150x150.png"],
             [[200,
               66],
              "assets/images/resized/0004/5663/45663v2-max-250x250.png"],
             [[200,
               66],
              "assets/images/resized/0004/5663/45663v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Kearny Venture Partners",
         "permalink": "kearny-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               13],
              "assets/images/resized/0006/0719/60719v1-max-150x150.png"],
             [[250,
               22],
              "assets/images/resized/0006/0719/60719v1-max-250x250.png"],
             [[450,
               41],
              "assets/images/resized/0006/0719/60719v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Athenian Venture Partners",
         "permalink": "athenian-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0003/6232/36232v4-max-150x150.jpg"],
             [[250,
               98],
              "assets/images/resized/0003/6232/36232v4-max-250x250.jpg"],
             [[450,
               177],
              "assets/images/resized/0003/6232/36232v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sigvion Capital",
         "permalink": "sigvion-capital",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0006/0147/60147v1-max-150x150.jpg"],
             [[241,
               64],
              "assets/images/resized/0006/0147/60147v1-max-250x250.jpg"],
             [[241,
               64],
              "assets/images/resized/0006/0147/60147v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "AgeChem Venture Fund",
         "permalink": "agechem-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               27],
              "assets/images/resized/0006/8086/68086v1-max-150x150.jpg"],
             [[250,
               45],
              "assets/images/resized/0006/8086/68086v1-max-250x250.jpg"],
             [[343,
               63],
              "assets/images/resized/0006/8086/68086v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.finsmes.com/2012/01/akebia-therapeutics-raises-4-1m-series-financing.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Akebia Therapeutics Raises $4.1M in Series B Financing",
    "raised_amount": 4100000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 1,
    "funded_day": 9,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novartis Bioventures",
         "permalink": "novartis-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0006/1683/61683v1-max-150x150.png"],
             [[250,
               98],
              "assets/images/resized/0006/1683/61683v1-max-250x250.png"],
             [[380,
               150],
              "assets/images/resized/0006/1683/61683v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Venture Investors",
         "permalink": "venture-investors",
         "image":
          {"available_sizes":
            [[[150,
               40],
              "assets/images/resized/0006/2067/62067v1-max-150x150.jpg"],
             [[217,
               58],
              "assets/images/resized/0006/2067/62067v1-max-250x250.jpg"],
             [[217,
               58],
              "assets/images/resized/0006/2067/62067v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Triathlon Medical Venture Partners",
         "permalink": "triathlon-medical-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0004/5663/45663v2-max-150x150.png"],
             [[200,
               66],
              "assets/images/resized/0004/5663/45663v2-max-250x250.png"],
             [[200,
               66],
              "assets/images/resized/0004/5663/45663v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Kearny Venture Partners",
         "permalink": "kearny-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               13],
              "assets/images/resized/0006/0719/60719v1-max-150x150.png"],
             [[250,
               22],
              "assets/images/resized/0006/0719/60719v1-max-250x250.png"],
             [[450,
               41],
              "assets/images/resized/0006/0719/60719v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Athenian Venture Partners",
         "permalink": "athenian-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0003/6232/36232v4-max-150x150.jpg"],
             [[250,
               98],
              "assets/images/resized/0003/6232/36232v4-max-250x250.jpg"],
             [[450,
               177],
              "assets/images/resized/0003/6232/36232v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sigvion Capital",
         "permalink": "sigvion-capital",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0006/0147/60147v1-max-150x150.jpg"],
             [[241,
               64],
              "assets/images/resized/0006/0147/60147v1-max-250x250.jpg"],
             [[241,
               64],
              "assets/images/resized/0006/0147/60147v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "AgeChem Venture Fund",
         "permalink": "agechem-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               27],
              "assets/images/resized/0006/8086/68086v1-max-150x150.jpg"],
             [[250,
               45],
              "assets/images/resized/0006/8086/68086v1-max-250x250.jpg"],
             [[343,
               63],
              "assets/images/resized/0006/8086/68086v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://www.finsmes.com/2013/06/akebia-therapeutics-completes-41m-series-financing.html",
    "source_description": "Akebia Therapeutics Completes $41M Series C Financing",
    "raised_amount": 41000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 6,
    "funded_day": 4,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novo A/S",
         "permalink": "novo-a-s",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0025/1103/251103v1-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-250x250.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Funds",
         "permalink": "novartis-ventures",
         "image":
          {"available_sizes":
            [[[150,
               14],
              "assets/images/resized/0004/4137/44137v1-max-150x150.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-250x250.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Kearny Venture Partners",
         "permalink": "kearny-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               13],
              "assets/images/resized/0006/0719/60719v1-max-150x150.png"],
             [[250,
               22],
              "assets/images/resized/0006/0719/60719v1-max-250x250.png"],
             [[450,
               41],
              "assets/images/resized/0006/0719/60719v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Venture Investors",
         "permalink": "venture-investors",
         "image":
          {"available_sizes":
            [[[150,
               40],
              "assets/images/resized/0006/2067/62067v1-max-150x150.jpg"],
             [[217,
               58],
              "assets/images/resized/0006/2067/62067v1-max-250x250.jpg"],
             [[217,
               58],
              "assets/images/resized/0006/2067/62067v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Athenian Venture Partners",
         "permalink": "athenian-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0003/6232/36232v4-max-150x150.jpg"],
             [[250,
               98],
              "assets/images/resized/0003/6232/36232v4-max-250x250.jpg"],
             [[450,
               177],
              "assets/images/resized/0003/6232/36232v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Triathlon Medical Venture Partners",
         "permalink": "triathlon-medical-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0004/5663/45663v2-max-150x150.png"],
             [[200,
               66],
              "assets/images/resized/0004/5663/45663v2-max-250x250.png"],
             [[200,
               66],
              "assets/images/resized/0004/5663/45663v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "AgeChem Venture Fund",
         "permalink": "agechem-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               27],
              "assets/images/resized/0006/8086/68086v1-max-150x150.jpg"],
             [[250,
               45],
              "assets/images/resized/0006/8086/68086v1-max-250x250.jpg"],
             [[343,
               63],
              "assets/images/resized/0006/8086/68086v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sigvion Capital",
         "permalink": "sigvion-capital",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0006/0147/60147v1-max-150x150.jpg"],
             [[241,
               64],
              "assets/images/resized/0006/0147/60147v1-max-250x250.jpg"],
             [[241,
               64],
              "assets/images/resized/0006/0147/60147v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Satter Investment Management",
         "permalink": "satter-investment-management",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "10151 Carver Road",
    "address2": "Suite 205",
    "zip_code": "45242",
    "city": "Cincinnati",
    "state_code": "OH",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}